Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Hepatitis C Testing Market Size, Value And Growth Trends Through 2030

The market for hepatitis C testing experienced robust expansion recently, projected to increase from $1.32 billion in 2025 to $1.4 billion in 2026, reflecting a compound annual growth rate of 6.4%. This historical growth trajectory was bolstered by factors such as the broadening of blood screening initiatives, an increasing incidence of hepatitis C infections, heightened awareness regarding diagnostics, the accessibility of sophisticated testing kits, and the proliferation of public health monitoring efforts.

Anticipated to experience considerable expansion over the coming years, the hepatitis C testing market’s valuation is projected to reach $1.78 billion by 2030, fueled by a compound annual growth rate of 6.1%. This upward trajectory throughout the forecast period is demonstrably linked to escalating worldwide efforts for hepatitis C elimination, a surge in the requirement for diagnostics administered at the point of care, broader accessibility to molecular testing methodologies, augmented financial commitments towards infectious disease diagnostics, and a heightened emphasis on initiating treatment promptly. Key developments anticipated within this timeframe encompass the increased integration of rapid diagnostic tools, a greater reliance on molecular testing technologies, a more pronounced concentration on early disease detection through screening, the proliferation of high-volume laboratory testing capabilities, and more sophisticated methods for tracking the efficacy of therapeutic interventions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

Hepatitis C Testing Market Growth Factors: Which Forces Are Supporting Market Expansion?

Anticipated growth in the hepatitis C testing market is being spurred by an increasing incidence of hepatitis cases. This viral infection, hepatitis C, targets the liver, causing inflammation and potentially severe harm if untreated. A significant factor contributing to the rise in hepatitis infections is the inadequacy of vaccination coverage, leaving substantial portions of the population vulnerable and enabling wider transmission of the virus. Early identification through hepatitis C testing is crucial for initiating timely treatment, thereby preventing liver damage and mitigating severe health consequences. Furthermore, it aids in identifying infected persons, which is instrumental in curbing the onward transmission and improving overall disease management strategies. Specifically, as of April 2024, the World Health Organization, a global health authority headquartered in Switzerland, reported that more than 50 million individuals worldwide are affected by chronic hepatitis C, with an estimated 1 million new cases emerging annually. Consequently, the escalating number of hepatitis cases is a key driver for the expansion of the hepatitis C testing market.

Hepatitis C Testing Market Segment Landscape: Which Areas Lead Market Development?

The hepatitis c testing market covered in this report is segmented –

1) By Test Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

2) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

3) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

4) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

Subsegments:

1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

Hepatitis C Testing Market Industry Trends: What Changes Are Reshaping Demand?

In the hepatitis C testing arena, leading enterprises are prioritizing the creation of sophisticated diagnostic tools, exemplified by dual antigen-antibody assays, to enhance the efficacy of both infection detection and ongoing patient management. These advanced tests are designed to identify viral proteins alongside the body’s defensive proteins, thus providing a comprehensive assessment of current and prior hepatitis C exposure. A prime illustration of this technological progression came in July 2023 when Roche Diagnostics India Pvt. Ltd., a prominent Indian entity in the diagnostics sector, introduced Elecsys HCV Duo. This automated immunoassay system possesses the unique capability to concurrently and distinctly identify both hepatitis C antigens and antibodies from a single patient sample, whether plasma or serum. Such a development facilitates earlier disease identification, aids in the effective management of individuals affected by the virus, and directly supports India’s national objective of eradicating hepatitis C by ensuring prompt and exhaustive screening protocols.

Hepatitis C Testing Market Industry Leaders And Market Competition

Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited

Access The Complete Hepatitis C Testing Market Report:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

Hepatitis C Testing Market Regional Outlook: Where Are The Largest Opportunities Located?

North Americawas the largest region in the hepatitis C testing market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model